Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda Targets Severe Epilepsies In Ovid Alliance

Jan 19 2017

• By Ian Haydock

Dravet Syndrome - Medical Report with Composition of Medicaments - Pills, Injections and Syringe

Related Content

Takeda Acquires Ariad In $5.2bn Deal – US Infrastructure A Key Component?

Jan 10 2017

Refocus, Optimize, Externalize: Takeda Overhauls Global R&D

Aug 01 2016

Related Companies

Takeda Pharmaceutical Co. Ltd.

ARIAD Pharmaceuticals, Inc.

Ovid Therapeutics, Inc.

H. Lundbeck A/S

Eisai Co., Ltd.

Zogenix, Inc.

GW Pharmaceuticals plc

Novartis AG

Pfizer Inc.

Additional Topics

Commercial Deals Neurology BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window